ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 16 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54,285 | -40.3% | 150,794 | -0.1% | 0.00% | – |
| Q3 2022 | $91,000 | -28.3% | 150,983 | -40.8% | 0.00% | – |
| Q2 2022 | $127,000 | -71.6% | 254,950 | -48.7% | 0.00% | – |
| Q1 2022 | $447,000 | +59.1% | 496,972 | +98.1% | 0.00% | – |
| Q4 2021 | $281,000 | -34.0% | 250,819 | +4.7% | 0.00% | – |
| Q3 2021 | $426,000 | -44.2% | 239,508 | +3.5% | 0.00% | – |
| Q2 2021 | $764,000 | +416.2% | 231,459 | +425.3% | 0.00% | – |
| Q1 2021 | $148,000 | 0.0% | 44,066 | -45.8% | 0.00% | – |
| Q4 2020 | $148,000 | +4833.3% | 81,277 | +4189.0% | 0.00% | – |
| Q3 2020 | $3,000 | -83.3% | 1,895 | -79.8% | 0.00% | – |
| Q2 2020 | $18,000 | +38.5% | 9,396 | -27.0% | 0.00% | – |
| Q1 2020 | $13,000 | -64.9% | 12,879 | -30.7% | 0.00% | – |
| Q4 2019 | $37,000 | – | 18,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |